We are live on ! Find out more
USNA icon

Usana Health Sciences

131 hedge funds and large institutions have $611M invested in Usana Health Sciences in 2014 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 31 increasing their positions, 55 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 19

32% more capital invested

Capital invested by funds: $463M → $611M (+$149M)

6% more funds holding

Funds holding: 124131 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.29% less ownership

Funds ownership: 97.13%96.84% (-0.29%)

44% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 55

Holders
131
Holders Change
+7
Holders Change %
+5.65%
% of All Funds
3.49%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
29
Increased
31
Reduced
55
Closed
19
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$118M -$47M -956,304 -29%
Renaissance Technologies
2
Renaissance Technologies
New York
$81.9M +$9.57M +194,966 +14%
Vanguard Group
3
Vanguard Group
Pennsylvania
$43.6M +$2.5M +50,984 +6%
Schroder Investment Management Group
4
Schroder Investment Management Group
United Kingdom
$37.1M -$84.9K -1,730 -0.2%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$35.5M -$502K -10,226 -1%
BIT
6
BlackRock Institutional Trust
California
$19.5M -$1.16M -23,666 -6%
LSV Asset Management
7
LSV Asset Management
Illinois
$17M -$15.6M -317,522 -49%
BFA
8
BlackRock Fund Advisors
California
$15.2M +$1.65M +33,578 +13%
Morgan Stanley
9
Morgan Stanley
New York
$12.6M +$4.44M +90,426 +58%
Deutsche Bank
10
Deutsche Bank
Germany
$10.4M +$3.17M +64,564 +47%
JP Morgan Chase
11
JP Morgan Chase
New York
$9.86M +$1.36M +27,666 +17%
State Street
12
State Street
Massachusetts
$9.82M -$242K -4,930 -3%
Northern Trust
13
Northern Trust
Illinois
$9.62M -$3.47M -70,632 -27%
BIM
14
Bogle Investment Management
Massachusetts
$8.03M +$7.68M +156,476 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$7.84M +$3.27M +66,518 +77%
Millennium Management
16
Millennium Management
New York
$7.75M +$7.42M +151,158 New
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$7.62M +$6.85M +139,468 +1,541%
Two Sigma Investments
18
Two Sigma Investments
New York
$7.36M +$6.57M +133,714 +1,375%
Norges Bank
19
Norges Bank
Norway
$7.21M -$2.65M -53,956 -28%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$6.94M +$3.59M +73,076 +118%
OAM
21
Oxford Asset Management
United Kingdom
$5.66M -$1.48M -30,228 -22%
UBS Group
22
UBS Group
Switzerland
$4.86M +$4.66M +94,838 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$4.65M -$806K -16,416 -15%
AQR Capital Management
24
AQR Capital Management
Connecticut
$4.51M +$2.61M +53,080 +152%
QI
25
QS Investors
New York
$4.02M +$3.85M +78,440 New

USNA Hedge Fund Activity: Q4 2014 in Review

131 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2014, worth a combined $611M — up 32% from $463M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new USNA positions and 19 closed out — a net gain of 10 holders — while 31 added to existing stakes and 55 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $9.57M. The largest seller was Fidelity Investments, cutting an estimated $47M.

  • 131 institutional investors held Usana Health Sciences (USNA) as of Q4 2014, up from 124 in Q3 2014.
  • Funds reported $611M of Usana Health Sciences stock for Q4 2014, up 32% quarter-over-quarter.
  • 29 funds opened new Usana Health Sciences positions in Q4 2014 and 19 closed out, a net change of +10 holders.
  • The largest Usana Health Sciences buyer in Q4 2014 was Renaissance Technologies, an estimated $9.57M added.
  • The largest Usana Health Sciences seller in Q4 2014 was Fidelity Investments, an estimated $47M sold.

Based on aggregated 13F filings for Q4 2014.